Research programme: estrogen receptor-alpha antagonists - Sumitomo
Alternative Names: ER-alpha antagonists research programme - Sumitomo; Estrogen receptor-alpha antagonists - Sumitomo; Research programme: ER-alpha antagonists - Sumitomo; TM 0001; TM 0002Latest Information Update: 30 Aug 2007
At a glance
- Originator Sumitomo Pharmaceuticals
- Class
- Mechanism of Action Estrogen receptor agonists; Estrogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 10 Feb 1999 Preclinical development for Postmenopausal osteoporosis in Japan (PO)